Drug Formularies
Most recent (9)
Article
""

Innovating for a customer-first future of health care

Learn more about the history of innovation at Express Scripts.

July 21, 25

Read More
Article
Leveraging biosimilars to drive savings and support patient access
July 01, 2024
By the end of 2024, 3 FDA-approved biosimilars to Stelara for patients living with inflammatory conditions will be closer to launch, enabling lower total drug spend.
Article
""

The importance of a clinical-first approach to formulary development

The clinical efficacy of a drug must always take priority over any other considerations when developing formularies.

Andy Behm, PharmD, BCGP, February 05, 24

Read More
Article
Here’s what drug makers don’t want you to know about PBMs
September 13, 2023
Pharmacy benefit managers shield patients from higher drug prices, but drug makers don’t want you to know that.
Article
With the right formulary, plans can control drug costs while preserving access
August 02, 2023
Each plan determines which formulary is best for its unique circumstances.
Article
""

Key considerations to support a robust biosimilar marketplace

We are taking a thoughtful and comprehensive approach to assessing biosimilar options that considers several factors.

July 24, 23

Read More